Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients. Muendlein A, Heinzle C, Brandtner EM, Leiherer A, et al. Breast Cancer Res Treat 2023 Jul 25. doi: 10.1007/s10549-023-07045.

Read + Share

Amedeo Smart

Independent Medical Education

Muendlein A, Heinzle C, Brandtner EM, Leiherer A, et al. Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients. Breast Cancer Res Treat 2023 Jul 25. doi: 10.1007/s10549-023-07045.
PMID: 37490173